22-OR: Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use

MLA

Peter Rossing, et al. “22-OR: Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use.” Diabetes, vol. 71, June 2022. EBSCOhost, https://doi.org/10.2337/db22-22-or.

APA

Peter Rossing, Stefan Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Vivian Fonseca, Guillermo E. Umpierrez, Luiza Caramori, Marc Lambelet, Prabhakar Viswanathan, Robert Lawatscheck, Amer Joseph, & George Bakris. (2022). 22-OR: Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use. Diabetes, 71. https://doi.org/10.2337/db22-22-or

Chicago

Peter Rossing, Stefan Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Vivian Fonseca, Guillermo E. Umpierrez, et al. 2022. “22-OR: Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use.” Diabetes 71 (June). doi:10.2337/db22-22-or.